-
「澳門銀河™」呈献「银河声荟：多明戈与友歌剧盛宴」震撼举行 盛况空前
-
支付宝电商平台“花言草语鲜花店”焕发浪漫商机，打造鲜花市场新潮流
-
揭秘广东嘉利得陶瓷有限公司为二线品牌瓷砖赢得差异化发展的市场空间
-
近千铁人齐聚，涌动城市沙滩 | 上海市第四届市民运动会铁人三项总决赛暨2024上海湾区铁人三项赛圆满落幕！
-
“看浦东，绘丝路”——“一带一路”文化教育交流论坛成功举办
-
IAM智能消毒空气净化器X5荣获星球奖产品设计创新奖
-
共生，共赢，共创——车少侠全新起航
-
The clock is ticking on Activeport's $5.3 Million Rights Issue
-
Amlan International Welcomes Pinyo Kantasakorn as Regional Sales Manager – Asia Pacific
-
Tealium recognized in Snowflake’s 2025 Modern Marketing Data Stack Report
-
松山棉店“家庭欢乐秀”：东方美学与温情时刻的完美融合
-
从走秀到生活：松山棉店丁松山如何用“家庭欢乐秀”深化品牌理念
-
庆祝新中国成立75周年 江山胜游--肖洪波·欧阳荷庚书画雅集特展
-
Treasure Global Inc Announces Strategic Service Partnership with Octagram Investment Limited
-
六联智能闪耀香港秋季电子展，AI与裸眼3D技术，引领科技潮流
-
Sportradar Deepens Official Partnership with NBA with Launch of Innovative, Value-Add Fan Engagement Solutions
-
Smart City Expo focuses its biggest edition on ethical and sustainable urban development
-
WillScot Announces Appointment of Worthing Jackman to Board of Directors
-
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
-
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
抖音平台集草师一次性小金管多肽美发笔涉嫌虚假宣传
三星官宣5月13日举行新品发布会，超轻薄Galaxy S25 Edge发布